Copyright: ©Author(s) 2026.
Figure 3 Therapeutic strategies targeting cardiovascular aging.
Interventions are categorized according to their current evidence level: Established therapies with cardiovascular outcome data (green), early-phase clinical studies with limited human evidence (yellow), and preclinical/experimental strategies requiring further validation (red). CVD: Cardiovascular disease; MI: Myocardial infarction; CRP: C-reactive protein; NMN: Nicotinamide mononucleotide.
- Citation: Liu Q, Wang YF, Geng Y, Zhang P, Lv TT. Cardiovascular aging as a modifiable biological process: Mechanisms, clinical phenotypes, and translational opportunities. World J Cardiol 2026; 18(8): 124876
- URL: https://www.wjgnet.com/1949-8462/full/v18/i8/124876.htm
- DOI: https://dx.doi.org/10.4330/wjc.124876